Ciclosporin in the treatment of myasthenia gravis.
Tindall
R S
RS
Department of Neurology, Southwestern Medical School, University of Texas Health Science Center, Dallas.
Phillips
J T
JT
Rollins
J A
JA
Greenlee
R G
RG
Wells
L
L
Belendiuk
G
G
D000328:Adult; D000368:Aged; D003524:Cyclosporins / Q000009:adverse effects / Q000627:therapeutic use*; D004311:Double-Blind Method; D004341:Drug Evaluation; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007674:Kidney Diseases / Q000139:chemically induced; D008297:Male; D008875:Middle Aged; D009157:Myasthenia Gravis / Q000188:drug therapy*; D011897:Random Allocation; D012307:Risk Factors
D003524:Cyclosporins